| Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120) |
|---|
| 06/17/2004 | CA2498089A1 Substituted (thiazol-2-yl) -amide or sulfonamide as glycokinase activators useful in the treatment of type 2 diabetes |
| 06/16/2004 | EP1427287A1 Pesticidal and parasitical di-and trifluorosubstituted alkene compounds |
| 06/16/2004 | EP1257556B1 Thiazolopyrimidines and their use as modulators of chemokine receptor activity |
| 06/16/2004 | EP0817635B1 Use of thiazepine, oxazepine and diazepine coumpounds for inhibiting hiv, herpesvirus and suppressing the immune system |
| 06/15/2004 | US6750349 Superior gastrokinetic properties |
| 06/15/2004 | US6750214 Quinoline and quinazoline compounds useful in therapy |
| 06/15/2004 | US6750024 Nitro-substituted non-fluorescent asymmetric cyanine dye compounds |
| 06/10/2004 | WO2004048368A2 Heteroarylsulfonylmethyl hydroxamic acids and amides and their use as protease inhibitors |
| 06/10/2004 | WO2004048363A1 Imidazole derivative, process for producing the same, and use |
| 06/10/2004 | WO2004048339A1 Isoquinoline compounds and medicinal use thereof |
| 06/10/2004 | US20040110778 A 3,10-diaza-benzo[e]azulene, 3,8,10-triaza-benzo[e]azulene, or 1,3a,6-triaza-as-indacene derivatives, used to treat anxiety, depression, a sleep disorder, or Alzheimer's dementia. |
| 06/10/2004 | US20040110764 Inhibit oncogene Ras; treating neurofibromin benign proliferative disorder; cancer (combination therapy); blindness, hepatitis infection, restenosis, polycystic kidney disease; imidazo[2,1-b]thiazole derivatives for example |
| 06/10/2004 | US20040110762 inhibitors of protein tyrosine kinase and are antiproliferative agents; 4-(4-phenoxyanilino)benzo[g]quinoline-3-carbonitrile for example; chemical intermediates, synthesis; treating polycystic kidney disease, colon polyps, cancer |
| 06/10/2004 | CA2507026A1 Imidazole derivatives, their production and use |
| 06/10/2004 | CA2506796A1 Heteroarylsulfonylmethyl hydroxamic acids and amides and their use as protease inhibitors |
| 06/09/2004 | EP1425001A1 Phenethanolamine derivatives for treatment of respiratory diseases |
| 06/09/2004 | CN1503781A Process for the preparatino of 1,3-substituted indenes and aryl-fused azapolycyclic compounds |
| 06/09/2004 | CN1152874C Antipsychotic 4 (1 H-indolyl-1-YL)-1-substituted piperidine derivatives |
| 06/09/2004 | CN1152860C Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides |
| 06/08/2004 | US6747053 Heteroaryl nitriles |
| 06/08/2004 | US6747032 Pyrimidin-4-one compounds |
| 06/03/2004 | WO2004046130A1 Pyridazinone derivatives as cdk2-inhibitors |
| 06/03/2004 | WO2004046117A1 Pyridazinone derivatives as gsk-3beta inhibitors |
| 06/03/2004 | WO2004045562A2 Mixed kappa/mu opioids and uses thereof |
| 06/03/2004 | WO2004027046A3 Methods of producing 4-amino-3-mercapto-triazoles |
| 06/03/2004 | WO2004014375A3 Fused bicyclic metalloproteinase inhibitors |
| 06/03/2004 | WO2003051842A3 Compositions decreasing activity of hormone-sensitive lipase |
| 06/03/2004 | US20040106661 Broadspecturm 2-amino-benzoxazole sulfonamide hiv protease inhibitors |
| 06/03/2004 | US20040106628 CX3CR1 receptor antagonists useful in the treatment or prophylaxis of neurodegenerative disorders, demyelinating disease and pain |
| 06/03/2004 | US20040106599 an aromatic or heteroaromatic amide compound useful as antiproliferative agent |
| 06/03/2004 | US20040106590 Methods and reagents for treating infections of clostridium difficile and diseases associated therewith |
| 06/03/2004 | CA2518917A1 Pyridazinone derivatives as cdk2-inhibitors |
| 06/03/2004 | CA2506022A1 Pyridazinone derivatives as gsk-3beta inhibitors |
| 06/02/2004 | EP0769966B1 Biotin compounds for targetting tumors and sites of infection |
| 06/02/2004 | CN1500800A Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (HBV) |
| 06/02/2004 | CN1152032C Pyridyl alkene- and pyridyl alkine-acid amides as cytostatics and immunosuppressives |
| 06/02/2004 | CN1152027C Polycyclic thiazole-2-subunit amines, producing process and uses in preparing medicament thereof |
| 06/01/2004 | USRE38524 Dipeptide derivatives as growth hormone secretagogues |
| 06/01/2004 | US6743913 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and α-1-blocking action |
| 05/27/2004 | WO2004043968A1 N-sulfonylaminothiazole |
| 05/27/2004 | WO2004043911A2 N-cycloalkylglycines as hiv protease inhibitors |
| 05/27/2004 | DE10252102A1 New 3-(piperidino- or -piperazino-alkyl)-indole derivatives, are 5HT-1A and/or 5HT-1D agonists and 5-HT reuptake inhibitors, useful e.g. for treating anxiety, depression or neurodegenerative diseases |
| 05/27/2004 | CA2505249A1 N-sulfonylaminothiazole |
| 05/26/2004 | EP1173176B1 Utilization of polycyclic 2-amino-thiazole systems in the production of medicaments for prophylaxis or treatment of obesity |
| 05/26/2004 | EP1123937B1 Substance gm-95, process for producing the same and utilization thereof |
| 05/26/2004 | CN1151161C Medicine nitrate salts |
| 05/25/2004 | US6740656 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 05/21/2004 | WO2004041818A1 Anti-infective agents |
| 05/21/2004 | WO2004041815A1 Indole derivative with 5ht1a affinity |
| 05/21/2004 | WO2004041285A1 Antiinflammation agents |
| 05/21/2004 | WO2004041210A2 Antibacterial agents |
| 05/21/2004 | WO2004041158A2 Rifalazil compositions and therapeutic regimens |
| 05/21/2004 | CA2502429A1 Antiinflammation agents |
| 05/20/2004 | US20040097728 Method for producing anellated tetrahydro-{1h}-triazoles |
| 05/20/2004 | US20040097501 Triazole compounds useful as protein kinase inhibitors |
| 05/20/2004 | US20040097492 For inhibiting hepatitis C virus (HCV) polymerase; therapy and prophylaxis of HCV infection |
| 05/20/2004 | US20040097485 For therapy and prophylaxis of disease or condition associated with inflammation, a metabolic disorder, infection, cancer or an immune disease or condition |
| 05/19/2004 | EP1419155A2 Piperidine derivatives as antibacterial agents |
| 05/19/2004 | EP1418909A2 2-amino-4, 5-trisubstituted thiaolyl derivatives and their use against autoimmune diseases |
| 05/19/2004 | EP1009738B1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 05/19/2004 | EP0975682B1 Group 8-10 transition metal olefin polymerization catalysts |
| 05/19/2004 | EP0947513B1 Tricyclic amine derivatives |
| 05/19/2004 | CN1496981A Cycloamine derivative and its use as medicine |
| 05/19/2004 | CN1150190C 4-(caminomethyl)-piperidine benzamides for treating gastrointestinal disorders |
| 05/19/2004 | CN1149996C Hexahydro-pyrido(4,3-B) indole derivatives as antipsychotic drugs |
| 05/18/2004 | US6737411 Racemization and enantiomer separation of clopidogrel |
| 05/18/2004 | CA2297279C New cyano-indole compounds that inhibit serotonin recapture, the process for their preparation and the pharmaceutical compounds that contain them |
| 05/13/2004 | WO2004039776A2 A process for the preparation of benzyl 2-oxo-4- (heteroaryl) dithio-alpha-isoprenyl-1- azetidineazetate derivatives |
| 05/13/2004 | US20040092740 Hyperpermeability; diabetic retinopathy, ischemic retinal-vein occlusion, prematurity, age-related macular degeneration |
| 05/13/2004 | US20040092737 Benzopiperidine derivatives |
| 05/13/2004 | US20040092559 Bicyclic modulators of androgen receptor function |
| 05/13/2004 | US20040092526 Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 05/13/2004 | US20040092503 Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 05/13/2004 | US20040092502 Central nervous system disorders; dietetics; psychological disorders; sleep disorders; sexual disorders |
| 05/13/2004 | DE10250080A1 Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel Selected CGRP antagonists, processes for their preparation and their use as medicaments |
| 05/12/2004 | EP1417162A1 Chromatographic separation of enantiomers of protected amino acids via smb-method |
| 05/12/2004 | EP1416798A2 THIAZOLO 4,5-b]PYRIDINES AS FUNGICIDES |
| 05/12/2004 | EP1028111B1 Amide derivatives or salts thereof |
| 05/12/2004 | EP1018514B1 NF-$g(k)B INHIBITORS CONTAINING INDAN DERIVATIVES AS THE ACTIVE INGREDIENT |
| 05/12/2004 | CN1495163A Novol pyrrole sulphamide compound |
| 05/11/2004 | US6734189 Hydroxamic and carboxylic acid derivatives |
| 05/11/2004 | US6734186 Phosphodiesterase 2 inhibitor |
| 05/11/2004 | US6734180 NF-κB inhibitor comprising an indan derivative as an active ingredient |
| 05/11/2004 | US6734158 Using 6-methyl-7-oxa-7-thia-4azaspiro(4.4)nonane |
| 05/06/2004 | WO2004037810A1 Selected cgrp antagonists, method for production and use thereof as medicament |
| 05/06/2004 | WO2004011460A3 Pyrazolylbenzothiazole derivatives and their use as therapeutic agents |
| 05/06/2004 | WO2003092580A3 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 05/06/2004 | US20040087595 1-aryl- or 1-alkylsulfony-heterocyclybenzazoles as 5-hydroxytryptamine-6 ligands |
| 05/06/2004 | US20040087581 Heterocyclylalkylamines as muscarinic receptor antagonists |
| 05/06/2004 | US20040087580 4-Hydroxy-2H-thieno[2,3-e]-1,2-thiazine-3-carboxamide-1,1-dioxides, process for preparing and pharmaceutical compositions thereof |
| 05/06/2004 | US20040087577 Anti-infective agents |
| 05/06/2004 | EP1415992A1 Diamine derivatives |
| 05/06/2004 | EP1414826A1 Therapeutically useful tetracyclic ligands |
| 05/06/2004 | EP1414795A1 Bicyclic modulators of androgen receptor function |
| 05/06/2004 | CA2503455A1 Selected cgrp antagonists, method for production and use thereof as medicament |
| 05/05/2004 | CN1494422A Use of GABAA inverse agonists in combination with nicotine receptor partial agonists, estrogen, selective estrogen modulators, or vitamin E for treatment of cognitive disorders |
| 05/05/2004 | CN1493291A Dicyclic compound capable of inhibiting epidermis growth factor acceptor rotatory tyrosine kinase |
| 05/05/2004 | CN1148372C Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha 1-blocking action |
| 05/04/2004 | US6730793 Two-photon responsive chromophores containing electron accepting core units |
| 04/29/2004 | WO2004035522A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein |